VANCOUVER, BRITISH COLUMBIA--(Marketwire - October 18, 2007) - Inflazyme Pharmaceuticals Ltd. (TSX: IZP) today announced that it has postponed its AGM and Special Meeting of Shareholders. The purpose of the meeting is to seek approval, if considered advisable, of the sale of the majority of Inflazyme’s research and development assets to Biolipox AB in return for $4 million in cash and up to $7 million in potential milestones and royalties. Originally scheduled for October 25, 2007, the AGM and Special Meeting will now be held at 9.00am (Pacific time) on November 16, 2007 at The Vancouver Marriott Pinnacle Downtown Hotel, 1128 West Hastings Street, Vancouver, BC, V6E 4RF, Canada.
